You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 18 Sep 2025
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Sep 2025
Regimen
Published Date: 18 Sep 2025
Cancer Type:
Gastrointestinal, 
Colorectal
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Sep 2025
Regimen
Published Date: 18 Sep 2025
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Sep 2025
Drug

Published Date: 18 Sep 2025

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New information sheet
Updated
Sep 2025
Regimen
Published Date: 18 Sep 2025
Cancer Type:
Breast, 
Central Nervous System, 
Endocrine, 
Adrenal, 
Neuroendocrine, 
Pancreatic Neuroendocrine, 
Parathyroid, 
Thymoma, 
Thyroid, 
Gastrointestinal, 
Anus, 
Colorectal, 
Esophagus, 
Gastric / Stomach, 
Gastrointestinal Stromal Tumours, 
Hepatobiliary / Liver / Bile Duct, 
Mesothelioma (Peritoneal), 
Neuroendocrine (GI), 
Pancreas, 
Rectal, 
Small bowel and appendix, 
Genitourinary, 
Bladder / Urothelial, 
Penile, 
Prostate, 
Renal cell / Kidney, 
Testis, 
Gynecologic, 
Cervix, 
Endometrial, 
Germ Cell, 
Gestational Trophoblastic Disease, 
Ovary, 
Uterine Sarcoma, 
Vagina, 
Vulva, 
Head and Neck, 
Larynx, 
Nasopharynx, 
Oral, 
Paranasal Sinus, 
Pharynx, 
Salivary Gland, 
Squamous Cell, 
Kaposi's Sarcoma, 
Lung, 
Mesothelioma (Pleural), 
Neuroendocrine (Lung), 
Non-Small Cell, 
Small Cell, 
Sarcoma, 
Desmoid Tumour, 
Ewing's, 
Ewing's and Soft Tissue, 
GIST, 
Giant Cell Tumour, 
Kaposi's Sarcoma, 
Osteogenic / Bone, 
Soft Tissue, 
Uterine, 
Wilm's Tumour, 
Skin, 
Basal Cell, 
Melanoma, 
Merkel Cell, 
Squamous Cell, 
Unknown Primary
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Expanded into full regimen monograph

Updated
Sep 2025
Regimen
Published Date: 16 Sep 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: No change; updated formatting

Updated
Sep 2025
Regimen
Published Date: 12 Sep 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Drug Regimen section

Sep 2025
Regimen
Published Date: 12 Sep 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Regimen section

Sep 2025
Regimen
Published Date: 12 Sep 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Regimen, Adverse Effects, Administration, Interactions, Pregnancy/Lactation, and Monitoring sections

Sep 2025
Drug

Published Date: 12 Sep 2025

Revision Summary:
Drug Monograph: Updated Pharmacokinetics, Adverse Effects, Dosing, Administration Guidelines, Pregnancy/Lactation, Interactions, and Monitoring sections
Patient Info Sheet EN: Updated/Revised drug information sheet
Sep 2025
Regimen
Published Date: 11 Sep 2025
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Drug Regimen, Cycle Frequency, Dose Modifications, Adverse effects, Administration Guidelines, and Monitoring sections; Added NDFP form

Sep 2025
Regimen
Published Date: 11 Sep 2025
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/Uses, Drug Regimen and Cycle Frequency sections; Added NDFP form

Sep 2025

Pages